Emerging evidence has indicated that CTGF is involved in the development of glomerulosclerosis, tubuloepithelial fibrosis and tubular atrophy, diseases that are characterized by the accumulation of extracellular matrix proteins, such as fibronectin and collagens. Here, CCN2 is linked to glomerulosclerosis.